SEC Form 4 · accession 0001156375-16-000250

CME GROUP INC. · CME

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Sr MD Chief Commercial Officer

Period of report

Oct 31, 2016

Accepted (ET)

Nov 1, 2016 · 3:43 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001156375

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock Class A	Oct 31, 2016	M	4,774	$54.30	A	58,454	D
Common Stock Class A^F1,F2	Oct 31, 2016	S	4,774	$99.9958	D	53,680	D
Common Stock Class A	Oct 31, 2016	M	10,226	$56.87	A	63,906	D
Common Stock Class A^F1,F2	Oct 31, 2016	S	10,226	$99.9958	D	53,680	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Non-Qualified Stock Option (right to buy)^F3	$54.30	Oct 31, 2016	M	4,774	D	Sep 15, 2014	Sep 15, 2020	Common Stock Class A	4,774	17,606	D
Non-Qualified Stock Option (right to buy)^F4	$56.87	Oct 31, 2016	M	10,226	D	Sep 15, 2013	Sep 15, 2019	Common Stock Class A	10,226	0	D

F1This sale was completed pursuant to the terms of a pre-arranged trading plan established in accordance with Rule 10b5-1.
F2On October 31, 2016, Mr. Durkin sold an aggregate of 15,000 shares of CME Group Class A common stock. For reporting purposes, the sales prices within a $1 range have been aggregated and the weighted average sales price has been reported. The price ranges were: $99.59 to $99.99 and $100.00 to $100.25. The Company maintains a record of the transactions and copies will be provided upon request.
F3On September 15, 2014, these options vested with respect to 100% of the granted number of shares covered by the option.
F4On September 15, 2013, these options vested with respect to 100% of the granted number of shares covered by the option.